Literature DB >> 25381413

Acetabular distraction: an alternative approach to pelvic discontinuity in failed total hip replacement.

N M Brown1, M Hellman1, B H Haughom1, R P Shah1, S M Sporer2, W G Paprosky2.   

Abstract

A pelvic discontinuity occurs when the superior and inferior parts of the hemi-pelvis are no longer connected, which is difficult to manage when associated with a failed total hip replacement. Chronic pelvic discontinuity is found in 0.9% to 2.1% of hip revision cases with risk factors including severe pelvic bone loss, female gender, prior pelvic radiation and rheumatoid arthritis. Common treatment options include: pelvic plating with allograft, cage reconstruction, custom triflange implants, and porous tantalum implants with modular augments. The optimal technique is dependent upon the degree of the discontinuity, the amount of available bone stock and the likelihood of achieving stable healing between the two segments. A method of treating pelvic discontinuity using porous tantalum components with a distraction technique that achieves both initial stability and subsequent long-term biological fixation is described. ©2014 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  total hip arthroplasty; revision total hip arthroplasty; pelvic distraction; acetabular bone loss; pelvic discontinuity

Mesh:

Year:  2014        PMID: 25381413     DOI: 10.1302/0301-620X.96B11.34316

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  10 in total

1.  [Treatment of acetabular defects with the trabecular metal revision system].

Authors:  G I Wassilew; V Janz; C Perka; M Müller
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

2.  CORR Insights®: Tantalum Components in Difficult Acetabular Revisions Have Good Survival at 5 to 10 Years: Longer Term Followup of a Previous Report.

Authors:  Rocco P Pitto
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

Review 3.  Treatment options for chronic pelvic discontinuity.

Authors:  Mark D Hasenauer; Wayne G Paprosky; Neil P Sheth
Journal:  J Clin Orthop Trauma       Date:  2017-09-18

4.  Custom triflange revision acetabular components for significant bone defects and pelvic discontinuity: Early UK experience.

Authors:  Hosam E Matar; Veenesh Selvaratnam; Nikhil Shah; Henry Wynn Jones
Journal:  J Orthop       Date:  2020-02-04

Review 5.  Acetabular Peri-Prosthetic Fractures-A Narrative Review.

Authors:  Gautier Beckers; Az-Eddine Djebara; Morgan Gauthier; Anne Lubbeke; Axel Gamulin; Matthieu Zingg; Johannes Dominik Bastian; Didier Hannouche
Journal:  Medicina (Kaunas)       Date:  2022-05-01       Impact factor: 2.948

Review 6.  Total hip arthroplasty in acetabular fractures.

Authors:  Deepak Gautam; Saurabh Gupta; Rajesh Malhotra
Journal:  J Clin Orthop Trauma       Date:  2020-10-17

7.  Three-Dimensional Models in Planning of Revision Hip Arthroplasty with Complex Acetabular Defects.

Authors:  Gennadiy M Kavalerskiy; Valeriy Y Murylev; Yaroslav A Rukin; Pavel M Elizarov; Alexey V Lychagin; Evgeniya Y Tselisheva
Journal:  Indian J Orthop       Date:  2018 Nov-Dec       Impact factor: 1.251

8.  Complex Reconstruction for Acetabular Pathologic Fracture in Unusual Chondroblastoma With Aneurysmal Bone Cyst.

Authors:  Paul Rizk; Gregory LaChaud; Ali Zarezadeh; Eugene Jang; Elham Nasri; Hernan A Prieto; Andre Spiguel
Journal:  Arthroplast Today       Date:  2022-02-28

9.  Feasibility and preliminary efficacy of tantalum components in the management of acetabular reconstruction following periacetabular oncologic resection in primary malignancies.

Authors:  Pengfei Zan; Xiaojun Ma; Hongsheng Wang; Zhengdong Cai; Jiakang Shen; Wei Sun
Journal:  Eur J Med Res       Date:  2022-08-17       Impact factor: 4.981

10.  Staged Total Hip Arthroplasty: A Novel Technique in Managing Native and Periprosthetic Acetabular Insufficiency.

Authors:  John V Horberg; J Ross Bailey; Kathleen Kay; D Gordon Allan
Journal:  Arthroplast Today       Date:  2021-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.